NS Pharmaceuticals

GPTKB entity

Statements (62)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition gptkb:XYZ_Biotech
gptkbp:advertising Direct-to-Consumer
B2B Partnerships
Digital_Marketing
Mr._Alan_Brown
gptkbp:awards Best Workplace 2022
gptkbp:budget 2022 Report
gptkbp:CEO gptkb:John_Doe
gptkbp:clinicalTrials Ongoing
Phase IV
Phase II
Phase III
Phase I
Phase III Trials
Real-World Evidence Studies
CNS Disorders
gptkbp:collaborations gptkb:Global_Pharma_Partners
Academic Institutions
Non-Profit_Organizations
International_Research_Networks
gptkbp:community_involvement Health Awareness Programs
gptkbp:community_service Patient Assistance Programs
gptkbp:culturalHeritage Inclusive Hiring Practices
gptkbp:employees 500
gptkbp:financialPerformance Strong Growth
gptkbp:focus Oncology
Neurology
Rare Diseases
gptkbp:founded 2000
gptkbp:founder Jane_Smith
gptkbp:headquarters gptkb:New_Jersey
https://www.w3.org/2000/01/rdf-schema#label NS Pharmaceuticals
gptkbp:industry Pharmaceuticals
gptkbp:investmentFocus Publicly Traded
$50 million in R&D
Venture_Capital_Funding
gptkbp:market gptkb:Asia
gptkb:North_America
Europe
Global
gptkbp:mission Innovate healthcare solutions.
gptkbp:partnerships Various Research Institutions
gptkbp:patentCitation Over_100_patents
gptkbp:products Prescription Drugs
gptkbp:regulatoryCompliance FDA_Approved
gptkbp:research gptkb:Dr._Emily_White
gptkbp:research_areas Cardiology
Immunology
Endocrinology
gptkbp:research_focus Gene Therapy
Biologics
Small Molecules
gptkbp:revenue $200 million
gptkbp:stockExchange NSP
gptkbp:subsidiary NS Biologics
gptkbp:supplyChain Global_Supply_Chain_Management
gptkbp:sustainability_initiatives Green Manufacturing Practices
gptkbp:targetMarket New_Drug_Launches_2023
gptkbp:training Continuous_Education_Programs
gptkbp:tributaryOf Multiple drug candidates
gptkbp:website www.nspharma.com